BIIB Biogen Inc.
Healthcare$193.76+2.26%ClosedMarket Cap: $28.61B
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$212.00
Target (Median)
$222.00
Target Range
$143.00 - $260.00
Upside from current price: 9.4%
Rating Distribution
3 Strong Buy18 Buy16 Hold1 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-15 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-05-01 | Citigroup | maintain | Neutral | Neutral |
| 2026-04-30 | Wedbush | maintain | Neutral | Neutral |
| 2026-04-30 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| 2026-04-30 | Guggenheim | maintain | Buy | Buy |
| 2026-04-30 | RBC Capital | maintain | Outperform | Outperform |
| 2026-04-22 | UBS | upgrade | Buy | Neutral |
| 2026-04-20 | Wells Fargo | upgrade | Overweight | Equal Weight |
| 2026-04-14 | Piper Sandler | upgrade | Overweight | Neutral |
| 2026-04-13 | Truist Securities | maintain | Hold | Hold |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $16.31 | $10.06B | 15 |
| Sun Dec 31 | $18.12 | $10.28B | 5 |
| Mon Dec 31 | $19.36 | $10.50B | 1 |
| Tue Dec 31 | $20.19 | $10.78B | 1 |